Literature DB >> 24603641

Calcium hydroxide suppresses Porphyromonas endodontalis lipopolysaccharide-induced bone destruction.

J Guo1, D Yang, H Okamura, J Teramachi, K Ochiai, L Qiu, T Haneji.   

Abstract

Porphyromonas endodontalis and its main virulence factor, lipopolysaccharide (LPS), are associated with the development of periapical diseases and alveolar bone loss. Calcium hydroxide is commonly used for endodontic therapy. However, the effects of calcium hydroxide on the virulence of P. endodontalis LPS and the mechanism of P. endodontalis LPS-induced bone destruction are not clear. Calcium hydroxide rescued the P. endodontalis LPS-suppressed viability of MC3T3-E1 cells and activity of nuclear factor-κB (NF-κB) in these cells, resulting in the reduced expression of interleukin-6 and tumor necrosis factor-α. In addition, calcium hydroxide inhibited P. endodontalis LPS-induced osteoclastogenesis by decreasing the activities of NF-κB, p38, and ERK1/2 and the expression of nuclear factor of activated T-cell cytoplasmic 1 in RAW264.7 cells. Calcium hydroxide also rescued the P. endodontalis LPS-induced osteoclastogenesis and bone destruction in mouse calvaria. Taken together, our present results indicate that calcium hydroxide suppressed bone destruction by attenuating the virulence of P. endodontalis LPS on bone cells.

Entities:  

Keywords:  bone resorption; interleukin-6; nuclear factor of activated T-cell cytoplasmic 1; osteoblasts; osteoclasts; tumor necrosis factor-α

Mesh:

Substances:

Year:  2014        PMID: 24603641     DOI: 10.1177/0022034514526886

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  8 in total

1.  Sirtuin 1 regulates matrix metalloproteinase-13 expression induced by Porphyromonas endodontalis lipopolysaccharide via targeting nuclear factor-κB in osteoblasts.

Authors:  Liu Qu; Yaqiong Yu; Lihong Qiu; Di Yang; Lu Yan; Jiajie Guo; Rabita Jahan
Journal:  J Oral Microbiol       Date:  2017-04-21       Impact factor: 5.474

2.  Involvement of interleukin‑23 induced by Porphyromonas endodontalis lipopolysaccharide in osteoclastogenesis.

Authors:  Nan Ma; Di Yang; Hirohiko Okamura; Jumpei Teramachi; Tomokazu Hasegawa; Lihong Qiu; Tatsuji Haneji
Journal:  Mol Med Rep       Date:  2016-12-14       Impact factor: 2.952

3.  MMP9 protects against LPS-induced inflammation in osteoblasts.

Authors:  Hongzhe Zhang; Lingshuang Liu; Chunmiao Jiang; Keqing Pan; Jing Deng; Chunyan Wan
Journal:  Innate Immun       Date:  2019-11-15       Impact factor: 2.680

4.  Resveratrol Suppresses Matrix Metalloproteinase-2 Activation Induced by Lipopolysaccharide in Mouse Osteoblasts via Interactions with AMP-Activated Protein Kinase and Suppressor of Cytokine Signaling 1.

Authors:  Yaqiong Yu; Xiaolin Li; Jing Mi; Liu Qu; Di Yang; Jiajie Guo; Lihong Qiu
Journal:  Molecules       Date:  2018-09-12       Impact factor: 4.411

5.  Chitosan oligosaccharide inhibits skull resorption induced by lipopolysaccharides in mice.

Authors:  Ke Guo; Zong Lin Liu; Wen Chao Wang; Wei Feng Xu; Shi Qi Yu; Shan Yong Zhang
Journal:  BMC Oral Health       Date:  2019-11-27       Impact factor: 2.757

6.  Lipopolysaccharide from Porphyromonas gingivalis, but Not from Porphyromonas endodontalis, Induces Macrophage M1 Profile.

Authors:  Pablo Veloso; Alejandra Fernández; Jessica Astorga; David González-Quintanilla; Alfredo Castro; Alejandro Escobar; Anilei Hoare; Marcela Hernández
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

7.  Physical properties and biocompatibility of an injectable calcium-silicate-based root canal sealer: in vitro and in vivo study.

Authors:  Eun-Su Lim; Young-Bae Park; Young-Sun Kwon; Won-Jun Shon; Kwang-Won Lee; Kyung-San Min
Journal:  BMC Oral Health       Date:  2015-10-21       Impact factor: 2.757

8.  Regenerative Endodontic Management of an Immature Molar Using Calcium Hydroxide and Triple Antibiotic Paste: a Two-Year Follow-Up.

Authors:  Mohannad Alasqah; Sulthan Ibrahim Raja Khan; Khalid Alfouzan; Ahmed Jamleh
Journal:  Case Rep Dent       Date:  2020-02-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.